EP 2797889 A4 20150603 - NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS
Title (en)
NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS
Title (de)
NEUARTIGE ARYLALKENDERIVATE UND DEREN VERWENDUNG ALS SELEKTIVE ÖSTROGENREZEPTORMODULATOREN
Title (fr)
NOUVEAUX DÉRIVÉS D'ARYLALCÈNE ET UTILISATION DE CEUX-CI EN TANT QUE MODULATEURS SÉLECTIFS DE RÉCEPTEUR D' STROGÈNE
Publication
Application
Priority
- CN 201110457898 A 20111230
- CN 201110456118 A 20111230
- US 201261646628 P 20120514
- US 201261646668 P 20120514
- CN 2012087884 W 20121228
Abstract (en)
[origin: WO2013097773A1] The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.
IPC 8 full level
C07D 213/61 (2006.01); C07C 217/20 (2006.01); C07C 255/54 (2006.01); C07D 207/08 (2006.01); C07D 207/12 (2006.01); C07D 213/38 (2006.01); C07D 213/64 (2006.01); C07D 213/65 (2006.01); C07D 213/70 (2006.01); C07D 213/74 (2006.01); C07D 231/56 (2006.01); C07D 235/06 (2006.01); C07D 239/34 (2006.01); C07D 263/56 (2006.01); C07D 285/14 (2006.01); C07D 295/096 (2006.01); C07D 307/79 (2006.01); C07D 307/82 (2006.01); C07D 333/16 (2006.01); C07D 333/28 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP KR)
A61K 31/44 (2013.01 - KR); A61K 31/505 (2013.01 - KR); A61P 3/10 (2017.12 - EP); A61P 5/30 (2017.12 - EP); A61P 5/32 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/02 (2017.12 - EP); A61P 15/12 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 215/48 (2013.01 - EP); C07C 217/18 (2013.01 - EP); C07C 217/20 (2013.01 - EP); C07C 255/54 (2013.01 - EP); C07D 207/09 (2013.01 - EP); C07D 207/12 (2013.01 - EP); C07D 213/38 (2013.01 - EP); C07D 213/61 (2013.01 - EP KR); C07D 213/63 (2013.01 - EP); C07D 213/64 (2013.01 - EP KR); C07D 213/74 (2013.01 - EP); C07D 231/56 (2013.01 - EP); C07D 239/34 (2013.01 - EP KR); C07D 285/10 (2013.01 - EP); C07D 307/81 (2013.01 - EP); C07D 307/82 (2013.01 - EP); C07D 333/20 (2013.01 - EP); C07D 333/28 (2013.01 - EP); C07D 405/06 (2013.01 - EP); C07D 405/12 (2013.01 - EP); C07C 2601/14 (2017.04 - EP)
Citation (search report)
- [XI] WO 2007062148 A2 20070531 - SMITHKLINE BEECHAM CORP [US], et al
- [XI] WO 2007062145 A2 20070531 - SMITHKLINE BEECHAM CORP [US], et al
- [XI] WO 2007062190 A2 20070531 - SMITHKLINE BEECHAM CORP [US], et al
- [XI] WO 2007062151 A2 20070531 - SMITHKLINE BEECHAM CORP [US], et al
- [XI] WO 2005033056 A2 20050414 - SMITHKLINE BEECHAM CORP [US], et al
- [XI] WO 02066415 A2 20020829 - TRINITY COLLEGE DUBLIN [IE], et al
- [XI] WO 0136360 A1 20010525 - HORMOS MEDICAL OY LTD [FI], et al
- [XI] WO 9907668 A1 19990218 - GLAXO WELLCOME INC [US]
- [XI] EP 0260066 A1 19880316 - NAT RES DEV [GB]
- See references of WO 2013097773A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2013097773 A1 20130704; AU 2012361344 A1 20140724; CA 2861939 A1 20130704; CN 105658628 A 20160608; EP 2797889 A1 20141105; EP 2797889 A4 20150603; JP 2015504049 A 20150205; KR 20150039705 A 20150413
DOCDB simple family (application)
CN 2012087884 W 20121228; AU 2012361344 A 20121228; CA 2861939 A 20121228; CN 201280065593 A 20121228; EP 12863580 A 20121228; JP 2014549345 A 20121228; KR 20147022291 A 20121228